SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice

Immunology and Cell Biology

Volumn 90, Issue 4, 2012, Pages 388-395

  Ji, Zhe ^a   Ke, Zun Ji ^a   Geng, Jian Guo ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

experimental autoimmune encephalomyelitis (EAE); P Selectin; serum amyloid P component (SAP)

Indexed keywords

ALPHA4 INTEGRIN; CD45 ANTIGEN; INTERLEUKIN 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PADGEM PROTEIN; SERUM AMYLOID P;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE INACTIVATION; IN VITRO STUDY; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; SPINAL CORD;

ADOPTIVE TRANSFER; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; INTEGRIN ALPHA4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; P-SELECTIN; SERUM AMYLOID P-COMPONENT; T-LYMPHOCYTES;

MUS; MUS MUSCULUS;

EID: 84860003041     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.51     Document Type: Article

References (51)

1. Pepys MB. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Phil Trans R Soc Lond B 2001; 356: 203-211. (Pubitemid 32241469)
2. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23: 337-366. (Pubitemid 40563173)
3. Bickerstaff MCM. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nature Med 1999; 5: 694-697. (Pubitemid 29289434)
4. Pepys MB. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA 1994; 91: 5602-5606. (Pubitemid 24174376)
5. Zahedi K. Characterization of the binding of serum amyloid P to laminin. J Biol Chem 1997; 272: 2143-2148. (Pubitemid 27058492)
6. Bickerstaff MCM, Botto M, Hutchinson W, Herbert J, Tennent G A, Bybee A. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999; 5: 694-697. (Pubitemid 29289434)
7. Pepys MB, Booth DR, Hutchinson WL, Gallimore JR, Collins PM, Hohenester E. Amyloid P component. A critical review. Amyloid. Int J Exp Clin Invest 1997; 4: 274-295.
8. Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature 2002; 417: 254-259. (Pubitemid 34534701)
9. Emsley J, White HE, O'Hara BP, Oliva G, Srinivasan N, Tickle IJ. Structure of pentameric human serum amyloid P component. Nature 1994; 367: 338-345. (Pubitemid 24062339)
10. Bharadwaj D, Mold C, Markham E, DuClos TW. Serum amyloid P component binds to Fcgamma receptors and opsonizes particles for phagocytosis. J Immunol 2001; 166: 6735-6741. (Pubitemid 32467217)
11. Du Clos TW. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Med Biol Rep 1996; 23: 253-260. (Pubitemid 27153049)
12. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504.
13. Lassmann H, Wisniewski HM. Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis. Arch Neurol 1979; 36: 490-497. (Pubitemid 9187999)
14. Bernard CC, Leydon J, Mackay IR. T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice. Eur J Immunol 1976; 6: 655-660.
15. Yasuda T, Tsumita T, Nagai Y, Mitsuzawa E, Ohtani S. Experimental allergic encephalomyelitis (EAE) in mice. I. Induction of EAE with mouse spinal cord homogenate and myelin basic protein. Jpn J Exp Med 1975; 45: 423-427.
16. Mendel I, Kerlero de RN, Ben Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vbexpression of encephalitogenic T cells. Eur J Immunol 1995; 25: 1951-1959.
17. Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 2005; 26: 485-495. (Pubitemid 41139258)
18. Engelhardt B, Vestweber D, Hallmann R, Schulz M. E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 1997; 90: 4459-4472. (Pubitemid 27508451)
19. Uboldi C, Doring A, Alt C, Estess P, Siegelman M, Engelhardt B. L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis. Eur J Immunol 2008; 38: 2156-2167.
20. Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci USA 1999; 96: 6896-6901. (Pubitemid 29274981)
21. Kerfoot SM, Kubes P. Overlapping roles of P-selectin and α4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 2002; 169: 1000-1006. (Pubitemid 34753459)
22. Kerfoot SM, Norman MU, Lapointe BM, Bonder CS, Zbytnuik L, Kubes P. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J Immunol 2006; 176: 6225-6234.
23. Chigaev A, Blenc AM, Braaten JV, Kumaraswamy N, Kepley CL, Andrews RP et al. Real time analysis of the affinity regulation of α4-integrin. J Biol Chem 2001; 276: 48670-48678.
24. Pepys MB, Rademacher TW, Amatayakul-Chantler S, Williams P, Noble GE, Hutchinson WL et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA 1994; 91: 5602-5606. (Pubitemid 24174376)
25. Hutchinson WL, Hohenester E, Pepys MB. Human serum amyloid P component is a single uncomplexed pentamer in whole serum. Mol Med 2000; 6: 482-493.
26. Pepys MB, Dash AC, Markham RE, Thomas HC, Williams BD, Petrie A. Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol 1978; 32: 119-124. (Pubitemid 8381273)
27. Steel DM, Whitehead AS. The major acute phase reactants c reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15: 81-88. (Pubitemid 24049801)
28. Walker E, Leemhuis T, Roeder W. Murine B lymphoma cell lines release functionally active interleukin 2 after stimulation with Staphylococcus aureus. J Immunol 1988; 140: 859-865. (Pubitemid 18067275)
29. Ho IC, Kim JI, Szabo SJ, Glimcher LH. Tissue specific regulation of cytokine gene expression. Cold Spring Harb Symp Quant Biol 1999; 64: 573-584. (Pubitemid 30329323)
30. Gaffen SL, Liu KD. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004; 28: 109-123. (Pubitemid 39313082)
31. Laurence A. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26: 371-381. (Pubitemid 46413906)
32. Kryczek I. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 2007; 178: 6730-6733. (Pubitemid 46847396)
33. Chen M, Geng JG. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch. Immunol Ther Exp 2006; 54: 75-84. (Pubitemid 44257345)
34. Austrup F, Vestweber D, Borges E, Löhning M, Bräuer R, Herz U et al. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 1997; 385: 81-83. (Pubitemid 27024558)
35. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4 integrin. Nature 1992; 356: 63-66.
36. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway Jr CA. Surface expression of α4 integrin by CD4T cells is required for their entry into brain parenchyma. J Exp Med 1993; 177: 57-68. (Pubitemid 23008085)
37. Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 1994; 145: 189-201. (Pubitemid 24217497)
38. Kent SJ, Karlik SJ, Cannon C, Hines DK, Yednock TA, Fritz LC et al. A monoclonal antibody to α4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol 1995; 58: 1-10.
39. Engelhardt B, Laschinger M, Schulz M, Samulowitz U, Vestweber D, Hoch G. The development of experimental autoimmune encephalomyelitis in the mouse requires α4-integrin but not α4b7-integrin. J Clin Invest 1998; 102: 2096-2105. (Pubitemid 29018816)
40. Engelhardt B, Vestweber D, Hallmann R, Schulz M. E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 1997; 90: 4459-4472. (Pubitemid 27508451)
41. + T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood 2003; 101: 4775-4782.
42. Piccio L, Rossi B, Scarpini E, Laudanna C, Giagulli C, Issekutz AC et al. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric Gi-linked receptors. J Immunol 2002; 168: 1940-1949. (Pubitemid 34135797)
43. Carvalho-Tavares J, Hickey M, Hutchison JJ, Michaud J, Sutcliffe IT, Kubes P. A role for platelets and endothelial selectins in tumor necrosis factor-α-induced leukocyte recruitment in the brain microvasculature. Circ Res 2000; 87: 1141-1148.
44. Yong T, Zheng MQ, Linthicum DS. Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J Neuroimmunol 1997; 80: 158-164. (Pubitemid 28015336)
45. Kerfoot SM, Kubes P. Overlapping roles of P-selectin and α4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 2002; 169: 1000-1006. (Pubitemid 34753459)
46. Piet E, Rob V, Atoosa F, Jeroen JMH, Willem AVG, Annemieke JMR. Neuroinflammation in plaque and vascular β-amyloid disorders: clinical and therapeutic implications. Neurodegener Dis 2008; 5: 190-193.
47. Pepys MB. Isolation of serum amyloid P-component (protein SAP) in the mouse. Immunology 1979; 37: 637-641. (Pubitemid 9227124)
48. Liu L, Huang D, Matsui M, He TT, Hu T, DeMartino J et al. Severe disease, unaltered leukocyte migration, and reduced IFN-γ production in CXCR3-/- mice with experimental autoimmune encephalomyelitis. J Immunol 2006; 176: 4399-4409. (Pubitemid 44264420)
49. Marusic S, Leach MW, Pelker JW, Azoitei ML, Uozumi N, Cui J et al. Cytosolic phospholipase A2α-deficient mice are resistant to experimental autoimmune encephalomyelitis. J Exp Med 2005; 202: 841-851. (Pubitemid 41345972)
50. Xia YF, Liu LP, Zhong CP, Geng JG. NF-κB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells. Biochem Biophys Res Commun 2001; 289: 851-856.
51. Liu LP, Xia YF, Yang L, DiDonato JA, DiCorleto PE, Zhong CP et al. B lymphocytes and plasma cells express functional E-selectin by constitutive activation of NF-κB. Biochem Biophys Res Commun 2001; 286: 281-291. (Pubitemid 32924910)